Matthew Harrison

Stock Analyst at Morgan Stanley

(3.34)
# 961
Out of 4,225 analysts
470
Total ratings
45.97%
Success rate
1.14%
Average return
Stock Action Price Target Current Upside Ratings Updated
PHVS
Pharvaris
Maintains: Overweight $34$32 $17.31
+84.86%
11 Nov 14, 2023
BIIB
Biogen
Maintains: Overweight $361$373 $232.06
+60.73%
32 Nov 10, 2023
GMAB
Genmab
Maintains: Underweight $33$32 $31.28
+2.30%
19 Nov 9, 2023
VRTX
Vertex Pharmaceuticals
Maintains: Equal-Weight $359$364 $351.00
+3.70%
14 Nov 8, 2023
ZNTL
Zentalis Pharmaceuticals
Maintains: Overweight $55$38 $10.61
+258.15%
3 Nov 7, 2023
REGN
Regeneron Pharmaceuticals
Maintains: Overweight $915$914 $808.59
+13.04%
8 Nov 3, 2023
CERE
Cerevel Therapeutics Holdings
Maintains: Overweight $42$38 $25.35
+49.90%
6 Nov 2, 2023
BMRN
BioMarin Pharmaceutical
Maintains: Overweight $125$117 $89.74
+30.38%
16 Nov 2, 2023
ARGX
argenx SE
Maintains: Overweight $604$607 $435.92
+39.25%
11 Nov 1, 2023
SRPT
Sarepta Therapeutics
Maintains: Overweight $183$146 $80.40
+81.59%
26 Oct 31, 2023
CNTA
Centessa Pharmaceuticals
Upgrades: Equal-Weight $4$8 $5.92
+35.14%
8 Oct 26, 2023
BGNE
BeiGene
Maintains: Overweight $321$319 $183.13
+74.19%
14 Aug 29, 2023
IOBT
IO Biotech
Maintains: Overweight $11$7 $1.22
+473.77%
3 Aug 15, 2023
PRME
Prime Medicine
Maintains: Equal-Weight $21$19 $7.17
+164.99%
3 Aug 14, 2023
TNYA
Tenaya Therapeutics
Maintains: Overweight $13$14 $1.86
+652.69%
4 Aug 10, 2023
ALEC
Alector
Reiterates: Equal-Weight $10 $5.43
+84.16%
6 Aug 7, 2023
MRNA
Moderna
Maintains: Equal-Weight $128$123 $79.01
+55.68%
19 Aug 4, 2023
INSM
Insmed
Reiterates: Overweight $41 $25.10
+63.35%
7 Aug 4, 2023
GILD
Gilead Sciences
Maintains: Equal-Weight $86$88 $75.23
+16.97%
23 Aug 4, 2023
TSVT
2seventy bio
Downgrades: Equal-Weight $25$13 $1.92
+577.08%
8 Jul 28, 2023
LEGN
Legend Biotech
Maintains: Overweight $65$85 $59.82
+42.09%
8 Jul 20, 2023
BLUE
bluebird bio
Reiterates: Underweight $3 $3.86
-22.28%
17 Jul 11, 2023
CMCSA
Comcast
Reiterates: Buy $46 $41.63
+10.50%
1 Apr 24, 2023
DNLI
Denali Therapeutics
Maintains: Overweight $61$63 $18.39
+242.58%
8 Apr 12, 2023
VIGL
Vigil Neuroscience
Maintains: Equal-Weight $12$13 $3.20
+306.25%
4 Mar 27, 2023
IVVD
Invivyd
Maintains: Underweight $2$1 $1.52
-34.21%
3 Mar 27, 2023
INVA
Innoviva
Maintains: Underweight $13$10 $13.69
-26.95%
8 Mar 3, 2023
FULC
Fulcrum Therapeutics
Downgrades: Equal-Weight $27$8 $4.80
+66.67%
8 Feb 28, 2023
GLPG
Galapagos NV
Maintains: Equal-Weight $57$44 $36.96
+19.05%
16 Feb 27, 2023
FUSN
Fusion Pharmaceuticals
Maintains: Overweight $19$10 $4.77
+109.64%
3 Jan 27, 2023
SANA
Sana Biotechnology
Maintains: Overweight $15$13 $4.19
+210.26%
3 Jan 24, 2023
LYEL
Lyell Immunopharma
Maintains: Equal-Weight $7$4 $1.67
+139.52%
4 Jan 24, 2023
EDIT
Editas Medicine
Maintains: Underweight $8$7 $10.61
-34.02%
10 Jan 24, 2023
BOLT
Bolt Biotherapeutics
Maintains: Equal-Weight $5$3 $0.89
+235.80%
4 Jan 24, 2023
BNTX
BioNTech SE
Maintains: Equal-Weight $203$216 $99.25
+117.63%
8 Jan 24, 2023
AVIR
Atea Pharmaceuticals
Maintains: Underweight $7$4 $2.95
+35.59%
7 Jan 24, 2023
ADCT
ADC Therapeutics
Maintains: Equal-Weight $7$5 $0.77
+549.35%
8 Jan 24, 2023
ABBV
AbbVie
Maintains: Overweight $178$182 $138.50
+31.41%
7 Dec 6, 2022
KOD
Kodiak Sciences
Maintains: Equal-Weight $12$9 $2.49
+261.45%
9 Nov 14, 2022
AKRO
Akero Therapeutics
Maintains: Equal-Weight $30$40 $16.66
+140.10%
5 Nov 7, 2022
AMGN
Amgen
Maintains: Overweight $279$282 $266.60
+5.78%
20 Nov 4, 2022
ALNY
Alnylam Pharmaceuticals
Maintains: Equal-Weight $220$210 $164.01
+28.04%
7 Oct 28, 2022
ALVR
AlloVir
Maintains: Overweight $32$27 $1.78
+1,416.85%
5 Sep 9, 2022
PFE
Pfizer
Maintains: Equal-Weight $55$52 $30.08
+72.87%
5 May 4, 2022
JNJ
Johnson & Johnson
Maintains: Equal-Weight $175$173 $152.11
+13.73%
3 Apr 6, 2022
SAGE
Sage Therapeutics
Maintains: Equal-Weight $61$57 $19.48
+192.61%
4 Mar 10, 2022
RARE
Ultragenyx Pharmaceutical
Maintains: Overweight $156$120 $39.11
+206.83%
5 Feb 1, 2022
BHVN
Biohaven Pharmaceutical Holding Company
Maintains: Equal-Weight $145$148 $32.11
+360.92%
9 Jan 7, 2022
MRK
Merck & Co.
Maintains: Equal-Weight n/a $101.13 - 4 Nov 29, 2021
BMY
Bristol-Myers Squibb Company
Maintains: Equal-Weight n/a $48.72 - 2 Oct 12, 2021
TSHA
Taysha Gene Therapies
Maintains: Overweight n/a $1.82 - 2 Aug 18, 2021
RPRX
Royalty Pharma
Maintains: Equal-Weight n/a $26.90 - 1 Aug 16, 2021
OGN
Organon & Co.
Maintains: Equal-Weight n/a $11.41 - 1 Aug 16, 2021
LLY
Eli Lilly
Maintains: Overweight n/a $591.86 - 1 Aug 4, 2021
TV
Grupo Televisa, S.A.B.
Initiates: Buy n/a $2.88 - 1 Jun 24, 2021
FRLN
Freeline Therapeutics Holdings
Maintains: Overweight n/a $6.34 - 1 Apr 6, 2021
RGNX
REGENXBIO
Maintains: Overweight n/a $18.61 - 4 Mar 8, 2021
HBAN
Huntington Bancshares
Maintains: Equal-Weight n/a $11.13 - 1 Feb 24, 2021
UBX
Unity Biotechnology
Downgrades: Equal-Weight n/a $1.94 - 2 Aug 18, 2020
EVLO
Evelo Biosciences
Downgrades: Equal-Weight n/a $0.41 - 1 May 21, 2020
INCY
Incyte
Maintains: Equal-Weight n/a $53.39 - 1 Jan 6, 2020
RDUS
Schnitzer Steel Industries
Maintains: Overweight n/a $25.39 - 4 Oct 11, 2018
CYTK
Cytokinetics
Assumes: Equal-Weight n/a $32.14 - 4 Sep 10, 2018